DIABETES MELLITUS, TYPE 2
Clinical trials for DIABETES MELLITUS, TYPE 2 explained in plain language.
Never miss a new study
Get alerted when new DIABETES MELLITUS, TYPE 2 trials appear
Sign up with your email to follow new studies for DIABETES MELLITUS, TYPE 2, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Diabetes drug adherence study ends early with just one participant
Disease control TerminatedThis study aimed to see if taking oral semaglutide exactly as directed helps control blood sugar in people with type 2 diabetes who are already on metformin. Only one person enrolled before the study was stopped early. The results are not available due to the small size.
Matched conditions: DIABETES MELLITUS, TYPE 2
Sponsor: Aalborg University Hospital • Aim: Disease control
Last updated May 22, 2026 13:52 UTC
-
Can a diabetes pill shield transplanted kidneys?
Disease control TerminatedThis study tested the drug empagliflozin (a diabetes medicine) in 20 kidney transplant recipients, some with type 2 diabetes and some without. The goal was to see if the drug could improve kidney function, heart structure, and blood sugar levels. The trial was stopped early, so r…
Matched conditions: DIABETES MELLITUS, TYPE 2
Phase: PHASE2 • Sponsor: Duke University • Aim: Disease control
Last updated May 22, 2026 13:50 UTC
-
Plant-Based diet aims to remission type 2 diabetes
Disease control TerminatedThis study looked at whether a plant-based diet and lifestyle changes could help people with type 2 diabetes, prediabetes, or obesity achieve remission or significant weight loss. Researchers tracked gut microbiome changes and health indicators over two years. The study was termi…
Matched conditions: DIABETES MELLITUS, TYPE 2
Phase: NA • Sponsor: National Council of Scientific and Technical Research, Argentina • Aim: Disease control
Last updated May 14, 2026 12:06 UTC
-
Hospital exercise study for diabetes halted early – only 4 patients enrolled
Knowledge-focused TerminatedThis study aimed to see if it's possible for hospitalized patients with type 2 diabetes to do daily resistance training. Researchers planned to enroll 24 patients but stopped early after only 4 joined. The goal was to learn if exercise during a hospital stay is practical and can …
Matched conditions: DIABETES MELLITUS, TYPE 2
Phase: PHASE1 • Sponsor: Rigshospitalet, Denmark • Aim: Knowledge-focused
Last updated May 26, 2026 06:52 UTC
-
Early diabetes drug trial halted after testing safety in just 14 people
Knowledge-focused TerminatedThis early-stage study tested the safety of an experimental drug called AP026 in healthy adults. The trial was stopped early and only enrolled 14 people instead of the planned 74. The main goal was to check for side effects, not to treat diabetes. Because the study was terminated…
Matched conditions: DIABETES MELLITUS, TYPE 2
Phase: PHASE1 • Sponsor: Chia Tai Tianqing Pharmaceutical Group Nanjing Shunxin Pharmaceutical Co., Ltd. • Aim: Knowledge-focused
Last updated May 22, 2026 14:04 UTC
-
Diabetes Drug's heart benefits probed in tiny study
Knowledge-focused TerminatedThis study aimed to understand how dapagliflozin, a diabetes medication, might improve blood vessel health in people with type 2 diabetes. Researchers planned to measure changes in blood pressure and other vascular markers in a small group of participants. The study was terminate…
Matched conditions: DIABETES MELLITUS, TYPE 2
Phase: PHASE4 • Sponsor: Boston University • Aim: Knowledge-focused
Last updated May 11, 2026 20:41 UTC
-
Pee test could reveal hidden pill skipping in diabetes patients
Knowledge-focused TerminatedThis study aimed to see if a urine test can accurately detect when people with type 2 diabetes are not taking their medications as prescribed. Researchers planned to compare the urine test results with standard methods like questionnaires and pharmacy refill records in 600 adults…
Matched conditions: DIABETES MELLITUS, TYPE 2
Sponsor: University of Leicester • Aim: Knowledge-focused
Last updated May 07, 2026 18:39 UTC